Higher incidence of hypercalcemia in patients receiving lithium therapy as determined by measurements of dialyzable and total calcium in serum
Publication
, Journal Article
Toffaletti, J; McComb, RB; Bowers, GN
Published in: Clinical Chemistry
January 1, 1979
Duke Scholars
Published In
Clinical Chemistry
ISSN
0009-9147
Publication Date
January 1, 1979
Volume
25
Issue
6
Related Subject Headings
- General Clinical Medicine
- 1103 Clinical Sciences
- 1101 Medical Biochemistry and Metabolomics
- 1004 Medical Biotechnology
Citation
APA
Chicago
ICMJE
MLA
NLM
Toffaletti, J., McComb, R. B., & Bowers, G. N. (1979). Higher incidence of hypercalcemia in patients receiving lithium therapy as determined by measurements of dialyzable and total calcium in serum. Clinical Chemistry, 25(6).
Toffaletti, J., R. B. McComb, and G. N. Bowers. “Higher incidence of hypercalcemia in patients receiving lithium therapy as determined by measurements of dialyzable and total calcium in serum.” Clinical Chemistry 25, no. 6 (January 1, 1979).
Toffaletti J, McComb RB, Bowers GN. Higher incidence of hypercalcemia in patients receiving lithium therapy as determined by measurements of dialyzable and total calcium in serum. Clinical Chemistry. 1979 Jan 1;25(6).
Toffaletti, J., et al. “Higher incidence of hypercalcemia in patients receiving lithium therapy as determined by measurements of dialyzable and total calcium in serum.” Clinical Chemistry, vol. 25, no. 6, Jan. 1979.
Toffaletti J, McComb RB, Bowers GN. Higher incidence of hypercalcemia in patients receiving lithium therapy as determined by measurements of dialyzable and total calcium in serum. Clinical Chemistry. 1979 Jan 1;25(6).
Published In
Clinical Chemistry
ISSN
0009-9147
Publication Date
January 1, 1979
Volume
25
Issue
6
Related Subject Headings
- General Clinical Medicine
- 1103 Clinical Sciences
- 1101 Medical Biochemistry and Metabolomics
- 1004 Medical Biotechnology